![Karl Kelley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karl Kelley active positions
Companies | Position | Start | End |
---|---|---|---|
RAIsonance, Inc.
![]() RAIsonance, Inc. Information Technology ServicesTechnology Services RAIsonance, Inc. is a family of companies based in the Denver Tech Center that specializes in artificial intelligence/machine learning-based healthcare solutions. The American company operates wellness products such as MyAdvocate and Biometric SoundPass for consumers, and the workforce wellness solution FCV Sentinel for the enterprise. Additionally, RAIsonance is developing diagnostic solutions for COVID-19, influenza, tuberculosis, and RSV. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use signal data signature recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. The company was founded in 2020 by Catherine M. Kolding, who has been the CEO since then. | Director/Board Member | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Career history of Karl Kelley
Statistics
International
United States | 2 |
Operational
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
RAIsonance, Inc.
![]() RAIsonance, Inc. Information Technology ServicesTechnology Services RAIsonance, Inc. is a family of companies based in the Denver Tech Center that specializes in artificial intelligence/machine learning-based healthcare solutions. The American company operates wellness products such as MyAdvocate and Biometric SoundPass for consumers, and the workforce wellness solution FCV Sentinel for the enterprise. Additionally, RAIsonance is developing diagnostic solutions for COVID-19, influenza, tuberculosis, and RSV. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use signal data signature recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. The company was founded in 2020 by Catherine M. Kolding, who has been the CEO since then. | Technology Services |
- Stock Market
- Insiders
- Karl Kelley
- Experience